When neurons get the blues

The most commonly prescribed antidepressants, selective serotonin reuptake inhibitors (SSRIs), lift the fog of depression for many people. But for around a third of people with major depressive disorder, SSRIs don’t make much of a difference. Now, researchers from the Salk Institute have pinned down a possible reason why — the neurons in at least some of these patients’ brains may become hyperactive in the presence of the drugs. The study appeared in Molecular Psychiatry on January 30, 2019.

“This is a promising step toward understanding why some patients don’t respond to SSRIs and letting us better personalize treatments for depression,” says Salk Professor Rusty Gage, the study’s senior author, president of the Institute, and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease.

Depression affects 300 million people around the world, and more than 6 percent of the US population experiences an episode of major depressive disorder (MDD) in any given year. MDD has been linked to an imbalance in serotonin signaling, although the exact mechanism is not well understood.

When brain cells signal with serotonin, the neurotransmitter is released from one cell, binds to receptors on neighboring cells, and is then transported back into the first cell. SSRIs increase levels of serotonin available for signaling by blocking the transporter that normally moves serotonin back inside cells, in a process known as reuptake.

Gage and his colleagues at Salk, along with collaborators at the Mayo Clinic, studied the range of responses to SSRIs in 803 patients with MDD. From this group, they selected three patients who achieved complete remission of their depression symptoms with SSRIs, as well as three patients with no improvement in their depression after taking SSRIs for eight weeks. The researchers isolated skin cells from all of these patients and from three healthy control subjects. They used stem cell reprogramming techniques to turn the skin cells into induced pluripotent stem cells (iPSCs), and from there into neurons.

“What’s exciting is that we could look directly at human cells, neurons that are not usually accessible in living patients,” says Krishna Vadodaria, a Salk staff scientist and first author of the new paper. “We can finally tap into the potential of looking at neurons from individuals whose medication histories, genetics and response profiles we know.”

The researchers studied how the neurons derived from each person responded to increased levels of serotonin, mimicking the effect of SSRIs. When serotonin was present, some neurons derived from SSRI non-responders had significantly higher activity on average compared to the neurons of healthy individuals or SSRI responders.

Further experiments pointed the team toward two particular serotonin receptors (out of seven known in the human brain), 5-HT2A and 5-HT7. When these receptors were blocked with a chemical compound, the neurons of non-responders were no longer hyperactive in the presence of serotonin, suggesting that drugs targeting these receptors may be effective alternates to SSRIs in some patients, but more research is needed.

The methods used in the new paper can be more broadly applied to other subsets of patients with depression, the researchers say.

“I hope this opens the door to many more studies of individuals who are extreme cases in terms of how they respond to treatments,” says Vadodaria. “In turn, that will help us understand major depression in the broader population.”

Other researchers on the study were Apua Paquola, Callie Fredlender, Kelly Heard, Yalin Deng, Amy Le, Sonia Dave, Lianna Fung, Xinyi Li and Maria Machetto of the Salk Institute; and Yuan Ji, Michelle Skime, Timothy Nelson, Daniel Hall-Flavin and Richard Weinshilboum of the Mayo Clinic.

The work and the researchers involved were supported by grants from the Robert and Mary Jane Engman Foundation, Lynn and Edward Streim, the Takeda-Sanford Consortium Innovation Alliance grant program, a Swiss National Science Foundation (SNSF) outgoing postdoctoral fellowship, a Minnesota Partnership Award for Biotechnology and Medical Genomics, an NIH-Mayo Clinic KL2 Mentored Career Development Award (NCAT UL1TR000135) and the Gerstner Family Mayo Career Development Award in Individualized Medicine.

Share Button

Fight or flight: Serotonin neurons prompt brain to make the right call

Known for its role in relieving depression, the neurochemical serotonin may also help the brain execute instantaneous, appropriate behaviors in emergency situations, according to a new Cornell study published Feb. 1 in Science.

The researchers studied brain activity patterns in mice. If a mouse was experiencing a threat, dorsal raphe serotonin neurons would fire during movements. But, when there was a calm, positive environment, these serotonin neurons would fire during pauses in active behavior.

“This switch really surprised us,” said senior author Melissa Warden, assistant professor and the Miriam M. Salpeter Fellow in the Department of Neurobiology and Behavior. “It was our first clue that something really strange might be going on in the brain in emergency situations.”

In emergency fight-or-flight situations, behavioral choices are different from the decisions an animal might make in less-critical situations. For example, if a mouse sits in the middle of an exposed field and a hawk spies it for food, the mouse may see the hawk start to swoop in and the mouse’s survival instinct tells it to run. The escape response is appropriate, Warden said.

“But if the hawk is flying overhead and it hasn’t seen the mouse, but the mouse has seen the hawk, it is appropriate for the mouse to freeze in place to avoid being detected,” she said. “In this situation, freezing in place is a better decision than attempting to flee, because the odds of survival are higher.”

In high-threat situations, stimulating serotonin neurons elicits escape attempts. In lower threat environments, stimulating these neurons causes pausing.

Thus, stimulating serotonin neurons is probably promoting the context-appropriate response. “It may cause animals to react to their environment, to do what’s appropriate in light of the current situation,” Warden said.

Like a global command center, serotonin sends signals all over the brain, she said. Fully understanding how this system prompts different behaviors in different environments may shed light on the role of other systems in the brain.

Said Warden: “Considering the widespread distribution of serotonin neurons throughout the brain, this finding raises the possibility that the ’emergency brain’ operates in a fundamentally different way.”

Co-lead authors Changwoo Seo and Akash Guru are both doctoral candidates in the field of neurobiology and behavior. In addition to Warden, Seo and Guru, the research, “Intense Threat Switches Dorsal Raphe Serotonin Neurons to a Paradoxical Operational Mode,” was co-authored by postdoctoral researcher Brianna J. Sleezer; doctoral candidate Yi-Yun Ho, M.Eng ’13; graduate student Brendan Ito; Christina Boada ’15, Michelle Jin ’17, Nicholas A. Krupa ’18, Durga Kullakanda ’19 and Cynthia X. Shen ’20; and Elias Wang ’16, a doctoral candidate at Stanford.

The research was funded by a Director’s New Innovator Award from the National Institutes of Health, the New York Stem Cell Foundation, the Alfred P. Sloan Foundation, the Whitehall Foundation, the Brain and Behavior Research Foundation, the Mong Family Foundation, and Cornell. Warden is a New York Stem Cell Foundation-Robertson Neuroscience Investigator.

Story Source:

Materials provided by Cornell University. Original written by Blaine Friedlander. Note: Content may be edited for style and length.

Share Button

Is breakfast always a good idea?

Research suggests eating breakfast won’t help adults lose weight, but it can be a good source of nutrients.

Share Button

Dentist ‘unfair’ fines investigated by watchdog

The watchdog is to investigate 400,000 penalty fines from visits to dentists.

Share Button

Health24.com | ‘Cocktail’ approach offers early hope for new male contraceptive

The research is in its early days, but Chinese scientists say they’re using bartenders’ tricks to stir up a new, reversible male contraceptive.

In experiments with rats, the method successfully kept sexually active males from impregnating females for more than two months.

“The two most widely used male contraceptives are condom and vasectomy,” noted a team led by Xiaolei Wang, of Nanchang University. “A reliable and reversible medium-term [2 to 20 weeks] contraceptive method between the one-off condom and permanent contraception is urgently needed.”

Their potential solution was inspired by the colourful layered cocktails often concocted by bartenders. In these mixes, liquids form distinct layers in a glass. But when stirred or heated, the layers combine into a uniform liquid.

Promising, but a long way to go

So, Wang’s group developed a form of male contraception in which layers of materials are injected into the vas deferens – the duct through which sperm travels from the testicle to the urethra – to block it.

The blockage continues until heat applied to the blocked area causes the layers to mix, breaking them down and thereby unplugging the vas deferens.

The Chinese group say they tested this method in male rats by injecting four layers of materials into the vas deferens. In sequence, the injected layers were: a hydrogel that forms a physical barrier to sperm; gold nanoparticles that heat up when irradiated with near-infrared light; ethylenediaminetetraacetic acid (EDTA), a chemical that breaks down the hydrogel and also kills sperm; and one more layer of gold nanoparticles.

While in place, the liquid layers in the vas deferens prevented the male rats from impregnating females for more than 2 months, Wang’s team reported Jan 30 in the journal ACS Nano.

But when the researchers shone a near-infrared lamp on the male rats for a few minutes, the layers mixed and dissolved, and the male rats were once again able to impregnate females. This offers “an effective and reversible manner to fill the gap of current medium-term contraceptive strategy” for men, the team said.

But, “though our method is promising, there is still a long way to go for practical practice,” the Chinese team said. “More animal experiments are needed to verify the safety of materials,” they said, and results in animals often fail to pan out in people.

One fertility expert in the United States agreed that much more study is needed.

“This study is a very preliminary look at injectable male contraception,” said Dr Mary Rausch, of Northwell Health Fertility in Manhasset, New York. “Though this has a long way to go before it would be ready for trial or certainly use in humans, it would be a medical breakthrough if it did come to fruition.

Share Button

Health24.com | Take the stairs: An ‘exercise snack’ can do wonders for your heart and lungs

Just a few exercise breaks – or “snacks” – a day can provide significant benefits, a new study says.

Specifically, it found that short sessions of intense stair climbing spaced throughout the day can improve heart and lung (cardiorespiratory) fitness.

An effective workout

“The findings make it even easier for people to incorporate ‘exercise snacks’ into their day,” said study senior author Martin Gibala. He’s a professor of kinesiology at McMaster University in Hamilton, Ontario, Canada.

“Those who work in office towers or live in apartment buildings can vigorously climb a few flights of stairs in the morning, at lunch and in the evening and know they are getting an effective workout,” Gibala said in a university news release.

Other studies have found that short bouts of vigorous exercise – sprint interval training (SIT) – are beneficial when done in a single 10-minute session, with a brief recovery period between intense bursts of activity.

In this study, researchers wanted to find out if bouts of intense stair climbing spread throughout the day would improve cardiorespiratory fitness.

Stronger and more powerful

For the research, sedentary young adults were divided into two groups of 12 people each. One group vigorously climbed three flights of stairs three times a day, with one to four hours between climbs. They did this three times a week over six weeks.

The other group did not exercise and served as the control.

“We know that sprint interval training works, but we were a bit surprised to see that the stair snacking approach was also effective,” said study co-author Jonathan Little. He’s an assistant professor of health and exercise science at the University of British Columbia’s Okanagan campus in Kelowna.

“Vigorously climbing a few flights of stairs on your coffee or bathroom break during the day seems to be enough to boost fitness in people who are otherwise sedentary,” Little said.

Along with having better heart and lung fitness, the stair climbers were stronger and generated more power during a cycling test than those in the control group, the study found.

The findings were published online in the journal Applied Physiology, Nutrition and Metabolism.

Image credit: iStock

Share Button

Health24.com | File mix-up leaves TB patient without treatment

Andile Ntombela (31) from Tongaat in KwaZulu-Natal was diagnosed with tuberculosis (TB) in August last year at Hambanathi Clinic. But three months later when she came to the clinic to collect her medication she was told by a staff nurse she no longer had TB.

The nurse, whose name is known to Health-e, told her the virus had been treated, so she returned home.

‘Weak and useless’

Ntombela said she knew TB treatment is supposed to last for six months, and so it troubled her that a qualified nurse kept insisting that she was in the clear. According to her, the sister kept on telling her that her file showed that she had completed her treatment. So for two months, during November and December last year, Ntombela stopped taking any medication.

“I didn’t have energy and strength to do anything. I felt weak and useless and much worse than I had the previous three months, until I received a call from the clinic earlier this month telling me to urgently come back to the clinic,” she said.

When she arrived at the clinic the same sister, who deals with TB patients at Hambanathi Clinic, told her a mistake had been made during her previous visit to the facility. The file she had looked at belonged to another patient – someone who had finished her treatment. There had been a mix-up of files.

Ntombela was then told that she needed to resume taking her pills.

“I was very angry at the time I was told about the mix-up. The sister didn’t even apologise or sympathise with me, she just gave me my January supplement and told me to come back next month to collect my February pills,” explained Ntombela.

No formal complaint received

Her brother Nhlakanipho said the family had also been surprised last November when she returned from the clinic without her medication.

“We thought because she was told by a professional that she is healed, so we didn’t worry too much. Up until she was called back to come and collect her medication. I don’t understand how a professional nurse could make such mistake,” said Nhlakanipho.

Nursing Service Manager Pretty Ndlovu of Hambanathi Clinic said she had never received a formal complaint, and so advised Ntombela to lodge a grievance according to normal procedures.

KZN Health spokesperson Agiza Hlongwane told OurHealth that the department would investigate.

“We will do a follow up on the matter raised and gather all the facts and rectify what was wronged,” he said. – Health-e News.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Neighbourhood Midwives closure: Mothers-to-be left ‘high and dry’

One women says she was “devastated” when an NHS midwifery service ended with just a week’s notice.

Share Button

The GP substitute will see you now

Some 20,000 physios, pharmacists and paramedics are to be recruited to work with under-pressure GPs.

Share Button

Regulate social media to protect children, MPs urge

A cross-party committee says social media companies should have a legal “duty of care” to children.

Share Button